Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial

Background: While there is a clear consensus for defining radioiodine-refractory differentiated thyroid cancer (RR-DTC), it is unknown whether these criteria are equally valid for determining when radioiodine (RAI) therapy is no longer beneficial and systemic treatment should be considered. Lenvatin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thyroid
Main Authors: Kiyota, Naomi, Robinson, Bruce, Shah, Manisha, Hoff, Ana O., Taylor, Matthew H., Li, Di, Dutcus, Corina E., Lee, Eun Kyung, Kim, Sung-Bae, Tahara, Makoto
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2017
Assuntos:
Thyroid Cancer and Nodules
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5646742/
https://ncbi.nlm.nih.gov/pubmed/28665259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2016.0549
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados